Smart Trainer Arm Ergometry Exercise Training in Individuals Post-Stroke
NCT ID: NCT05410600
Last Updated: 2024-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1 participants
INTERVENTIONAL
2023-03-15
2023-05-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multimodal Exercise Training Poststroke
NCT03174392
Machines Assisting Recovery From Stroke
NCT02787694
Energy Consumption and Cardiorespiratory Load During Robot-Assisted Gait Training in Non-Ambulatory Stroke Patients
NCT02995616
To Develop a Walking Exercise Program for Non-ambulatory Stroke Survivors
NCT06247553
Understanding Different Parameters in Locomotor Training (a Type of Walking Training) for Person After a Stroke
NCT00712179
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In our previous protocol (IRB-300001384) we explored the power output curves of people post stroke compared with non-impaired individuals during one arm versus two arm cycling exercise using the smart trainer arm ergometer. The work demonstrated the potential benefit of interactive exercise for those with physical disabilities. The purpose of this study is to examine changes in power output, oxygen consumption, cognitive function, and quality of life after 8 weeks of smart trainer arm ergometry exercise training among individuals who have a stroke-based limb impairment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm Ergometer Smart Trainer Cycling
Participants will participate in an 8-week exercise training program using the smart trainer.
Arm ergometer smart trainer cycling program
Arm ergometer exercise training using the smart trainer.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Arm ergometer smart trainer cycling program
Arm ergometer exercise training using the smart trainer.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 40-70 years
* Able to use both arms during arm cycling exercise (i.e., able to complete the 10 revolution pre-test)
Exclusion Criteria
* No movement in one arm or have an injury that prevents safe use of one arm during exercise
* Unable to complete the 10 revolution pre-test
* Unstable cardiovascular conditions
* Unable to understand study directions
40 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
James Rimmer
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James H Rimmer, PhD
Role: PRINCIPAL_INVESTIGATOR
UAB School of Health Professions
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
WHARF
Homewood, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
90REGE000
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
IRB-300009387
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.